Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
This report summarises key issues related to HIV and people who inject drugs in Europe and Central Asia as well as identifies priority options for action to improve the HIV response for this population.
Government, civil society and community representatives discussed the state of play of debates in Vienna as well as developments in the field of human rights, development, public health and novel trends.